Central Bank & Trust’s ContraFect Corporation CFRX Stock Holding History

Central Bank & Trust’s Portfolio CFRX Stock Details CFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14	Closed	-$6	–	363
2023 Q3	$6	Hold	14	–	–	﹤0.01%	334
2023 Q2	$20	Hold	14	–	–	﹤0.01%	324
2023 Q1	$23	Sell	14 -1	-7%	-$5	﹤0.01%	427
2022 Q4	$109	Sell	15 -143	-91%	-$1.65K	﹤0.01%	335
2022 Q3	$2K	Buy	158 +19	+14%	+$959	﹤0.01%	306
2022 Q2	$34K	Buy	139 +83	+148%	+$23.4K	0.01%	241
2022 Q1	$16K	Hold	56	–	–	﹤0.01%	269
2021 Q4	$12K	Buy	56 +25	+81%	+$6.86K	﹤0.01%	280
2021 Q3	$10K	Buy	+31	New	+$9.65K	﹤0.01%	272

Other funds holding CFRX

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Central Bank & Trust's CFRX Position: Q4 2023 in Review

Central Bank & Trust sold out of ContraFect Corporation (CFRX) in Q4 2023, closing a stake of 14 shares — an estimated $6 sold.

Central Bank & Trust first reported a position in CFRX in Q3 2021 and held it in 9 quarters. The position peaked at $34K in Q2 2022. 2 funds tracked by Wall St. Rank hold CFRX as of Q4 2023.

Central Bank & Trust reported no remaining ContraFect Corporation position as of Q4 2023 after selling out during the quarter.
Central Bank & Trust sold 14 ContraFect Corporation shares in Q4 2023, an estimated $6.
Central Bank & Trust first reported a position in ContraFect Corporation in Q3 2021 and held it in 9 quarters.
Central Bank & Trust's ContraFect Corporation position peaked at $34K in Q2 2022.
2 funds tracked by Wall St. Rank held ContraFect Corporation as of Q4 2023.

Based on Central Bank & Trust's 13F filing for Q4 2023, filed 9 Jan 2024.